Population Screening in Health Systems.

Applications of genomics to population screening are expanding in the United States and internationally. This review examines these genomic population screening programs to identify common features and differences in screened conditions, genomic technology employed, approach to results disclosure, health outcomes, financial models, and sustainability.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 Many of these programs are being implemented in the context of healthcare systems, mostly in a clinical research setting, but there are some emerging examples of clinical models.
• 2 This review examines these genomic population screening programs to identify common features and differences in screened conditions, genomic technology employed, approach to results disclosure, health outcomes, financial models, and sustainability.
• 3 The diversity of approaches provides opportunities to learn and better understand the optimal approach to implementation based on the contextual setting.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: